2001
DOI: 10.1021/jo0106344
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis of DTPA Analogues Derived from Piperidine and Azepane:  Potential Contrast Enhancement Agents for Magnetic Resonance Imaging

Abstract: Two DTPA derivatives (PIP-DTPA and AZEP-DTPA) as potential contrast enhancement agents in MRI are synthesized. The T1 and T2 relaxivities of their corresponding Gd(III) complexes are reported. At clinically relevant field strengths, the relaxivities of the complexes are comparable to that of the contrast agent, Gd(DTPA) which is in clinical use. The serum stability of the (153)Gd-labeled complexes is assessed by measuring the release of (153)Gd from the ligands. The radiolabeled Gd chelates are found to be kin… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
26
0

Year Published

2003
2003
2015
2015

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 36 publications
(26 citation statements)
references
References 38 publications
(24 reference statements)
0
26
0
Order By: Relevance
“…There are few published reports on the r 2 NMRD profiles of Gd 3þ -based small molecular or macromolecular complexes. 29,30 Gd-SWCNTs have distinctly different r 2 NMRD profiles than Gd 3þ -based small molecular or macromolecular complexes. At clinically relevant 1.5 T magnetic field (proton Larmor frequency ¼ 61.73 MHz), the r 2 value is 170 mM À1 s À1 , which is an order of magnitude greater than any current Gd 3þ -based FDA-approved MRI …”
mentioning
confidence: 96%
“…There are few published reports on the r 2 NMRD profiles of Gd 3þ -based small molecular or macromolecular complexes. 29,30 Gd-SWCNTs have distinctly different r 2 NMRD profiles than Gd 3þ -based small molecular or macromolecular complexes. At clinically relevant 1.5 T magnetic field (proton Larmor frequency ¼ 61.73 MHz), the r 2 value is 170 mM À1 s À1 , which is an order of magnitude greater than any current Gd 3þ -based FDA-approved MRI …”
mentioning
confidence: 96%
“…The same reaction in CH 3 CN was slightly more efficient in providing the product ( S )- 11 (53%). Later, ( R )- 3b was subjected to the reaction with AgClO 4 for formation of aziridinium ion ( S )- 4b’ that was reacted with different amines in the regiospecific and stereospecific manner. The ring opening reaction of ( S )- 4b’ at the less hindered carbon (C3) with the amines at room temperature for 2 h afforded the substitution vicinal amine analogues 11, 13 , and 14 in excellent isolated yield (>92%).…”
Section: Resultsmentioning
confidence: 99%
“…1,78,1112 It should be noted that substitution of a functional group onto the carbon backbone of DTPA will lead to generation of a stereocenter, and the stereochemistry in chelating agents was demonstrated to affect stability and biological activity of their metal complexes. 4,1315 …”
Section: Introductionmentioning
confidence: 99%
“…Therefore, the increase in rigidity of the ligand backbone has been investigated as a possible strategy to achieve a higher stability of the corresponding Gd III complex as found for rigidified DTPA derivatives. 5,6 In these cases the increased ligand rigidity was shown to enhance mainly the kinetic inertness of the Gd III complexes and thus to improve the in vivo stability as compared to their parent compounds. 5,6 We have recently demonstrated that the "rigidification" of the oxyethylenic bridge of EGTA by incorporation of an aromatic group does not significantly alter the thermodynamic stability and the structural properties of the Ln III complexes.…”
Section: Introductionmentioning
confidence: 99%